Reports
Sale
Global Stem Cell Therapy Market Size, Trends, Growth, Report: By Treatment: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy, Syngeneic Stem Cell Therapy; By Product Type: Adult Stem Cell, Human Embryonic Cell, Others; By Application; By Technology; By End User; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Stem Cell Therapy Market Outlook
The global stem cell therapy market size was valued at USD 246 million in 2023, driven by the increasing demand for regenerative therapies structure across the globe. The market size is anticipated to grow at a CAGR of 18.5% during the forecast period of 2024-2032 to achieve a value of USD 1133.4 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Stem cell therapy is a specialised form of regenerative medicine that aims to repaid damaged cells by modulating the immune system and reducing inflammation. The capabilities of stem cell therapy offers immense potential for treatment of various medical conditions ranging from autoimmune and trauma injuries to inflammatory, orthopaedic, and neurological conditions. Instead of directly targeting the conditions, stem cell therapy aims at helping the body of the patient heal itself against the condition. Stem cell therapy utilises stem cells, the cells from which other cells are generated for specific functions, or derivatives of stem cells to trigger the body‘s healing.
- The increasing prevalence of chronic conditions such as cancer, musculoskeletal and cardiovascular diseases, and leukaemia, among others, is driving the stem cell therapy market growth. In addition, the market growth is getting fuelled by the rising health awareness, rising disposable income, and sedentary lifestyles led by the working population.
- The increasing geriatric population, along with the surge in oncological, neurological, and orthopaedic conditions cases associated with them is anticipated to provide impetus to the stem cell therapy market in the forecast period. The market is anticipated to be aided by the increasing prevalence of wounds and injuries, infused by the growing inclination of youth towards sports and adventure.
- The rising healthcare expenditure and technological advancements in the healthcare infrastructure across the emerging economies are improving the diagnosis and treatment standards across the healthcare units which are further boosting the market growth.
- The growing research and development activities, favoured by fundings and initiatives by various governments, aimed towards innovating in the field of stem cell research are the crucial stem cell therapy market trends.
Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on treatment type, the market is segmented into allogeneic stem cell therapy, autologous stem cell therapy, syngeneic stem cell therapy. On the basis of product type, the stem cell therapy market is classified into adult stem cell, human embryonic cell, and pluripotent stem cell, among others. By application, the market is categorised into musculoskeletal disorders, neurological disorders, oncology disorders, cardiovascular disorders, cancer, and wounds and injuries, among others. The regional markets for stem cell therapy are divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global stem cell therapy market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Thermo Fisher Scientific
- Bayer AG
- Takeda Pharmaceutical Company Limited
- MEDIPOST Co., Ltd.
- JCR Pharmaceuticals Co., Ltd.
- Astellas Pharma Inc.
- Mesoblast Ltd.
- Novadip Biosciences S.A.
- Nuvasive Inc
- Amgen Inc
- Others
Market Share by Treatment Type
The allogeneic stem cell therapy segment is expected to witness a healthy growth in the forecast period, increasing its stem cell therapy market share. In this treatment procedure, stem cells are matched from a donor and transplanted into the patient whose immune system gets a boost after other types of treatment are administered. While the transplanted stem cells do help in improving the immune system of the patient and in fighting against conditions such as cancers, there is a risk of rejection with the stem cells getting targeted and destroyed by the patient’s immune system.
Syngeneic stem cell therapy, based on treatment type, has a high success rate, however, is restricted in applications as stem cells are sourced from identical twins of the patient. This type of stem cell therapy is uses to treat various types of conditions such as Hodgkin lymphoma, leukaemia, multiple myeloma, Myelodysplastic syndrome, Non-Hodgkin lymphoma, severe aplastic anaemia, and testicular cancer, among others. Moreover, in this therapy, as stem cells are donated by healthy identical twins, reducing risks of rejection or host versus graft disease, increasing the success rate of the procedure significantly.
Market Share by Product Type
Based on product type, the human embryonic cell segment accounts for a significant share in the stem cell therapy market. This can be attributed to the versatility of this type of cell which makes it effective in the treatment and repair of diseased organs or tissues. In addition, human embryonic cell accelerate the therapy process by dividing into more stem cells than any other product type. With the increase in in-vitro fertilisation clinics and operations, extracting human embryonic cells has become easier.
On the other hand, the adult stem cell segment is expected to witness a heightened growth in the forecast period. Adult stem cells are present in the most critical areas of the body such as intestine, muscle, brain, and heart. Hence, these types of cells can facilitate the regeneration of cells which can treat chronic heart or muscle-related conditions. The targeted applications of these cells and easy availability amongst a growing population is further expected to influence the stem cell therapy market price.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Thermo Fisher Scientific is a key supplier of scientific instruments, reagents, and consumables. The company caters to the demands of medical science by providing custom-tailored solutions, biotech products, medical devices, pharmaceuticals, drug innovations, and medicines, among others. Thermo Fisher Scientific was founded in 1956 and is headquartered in Massachusetts, United States.
Bayer AG is a leading pharmaceutical company which develops, discovers, innovates, manufactures, and markets products which cater to the demands of human health treatment and agriculture. The company offers products which are applied in the treatment of cardiovascular diseases, women’s health, cancer, and ophthalmological diseases, among others. Bayer AG was established in 1863 in Barmen, Germany.
Takeda Pharmaceutical Company Limited is a global research-based company which focuses on developing high-end pharmaceuticals. This company facilitates research and development activities and clinical trials, with a focus on oncological, neuroscience, gastroenterology, and plasma-derived therapies, among others. It was founded in 1781 and is headquartered in Osaka, Japan.
Other market players include MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Astellas Pharma Inc., Mesoblast Ltd., Novadip Biosciences S.A., Nuvasive Inc, and Amgen Inc, among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment |
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Technology |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Stem Cell Therapy Market Overview
3.1 Global Stem Cell Therapy Market Historical Value (2017-2023)
3.2 Global Stem Cell Therapy Market Forecast Value (2024-2032)
4 Global Stem Cell Therapy Market Landscape
4.1 Global Stem Cell Therapy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Stem Cell Therapy Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Treatment
4.2.3 Analysis by Applications
5 Global Stem Cell Therapy Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Stem Cell Therapy Market Segmentation
6.1 Global Stem Cell Therapy Market by Treatment
6.1.1 Market Overview
6.1.2 Allogeneic Stem Cell Therapy
6.1.3 Autologous Stem Cell Therapy
6.1.4 Syngeneic Stem Cell Therapy
6.2 Global Stem Cell Therapy Market by Product Type
6.2.1 Market Overview
6.2.2 Adult Stem Cell
6.2.2.1 Hematopoietic Stem Cells (Blood Stem Cells)
6.2.2.2 Mesenchymal Stem Cells
6.2.2.3 Neural Stem Cells
6.2.2.4 Epithelial/Skin Stem Cells
6.2.2.5 Other Adult Stem Cells
6.2.3 Human Embryonic Cell
6.2.4 Pluripotent Stem Cell
6.2.5 Others
6.3 Global Stem Cell Therapy Market by Application
6.3.1 Market Overview
6.3.2 Musculoskeletal Disorders
6.3.3 Neurological Disorders
6.3.4 Oncology Disorders
6.3.5 Cardiovascular Disorders
6.3.6 Cancers
6.3.7 Wounds and Injuries
6.3.8 Others
6.4 Global Stem Cell Therapy Market by Technology
6.4.1 Market Overview
6.4.2 Cell Acquisition
6.4.2.1 Bone Marrow Harvest
6.4.2.2 Umbilical Blood Cord
6.4.2.3 Apheresis
6.4.3 Cell Production
6.4.3.1 Therapeutic Cloning
6.4.3.2 In Vitro Fertilization
6.4.3.3 Cell Culture
6.4.3.4 Isolation
6.4.4 Cryopreservation
6.4.5 Expansion And Sub-Culture
6.5 Global Stem Cell Therapy Market by End User
6.5.1 Market Overview
6.5.2 Pharmaceutical And Biotechnology Companies
6.5.3 Hospitals & Cell Banks
6.5.4 Academic & Research Institutes
6.6 Global Stem Cell Therapy Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Stem Cell Therapy Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Stem Cell Therapy Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Stem Cell Therapy Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Stem Cell Therapy Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Stem Cell Therapy Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Supplier Landscape
18.1 Thermo Fisher Scientific
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Bayer AG
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Stem Cell Therapys International Group, Ltd.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Takeda Pharmaceutical Company Limited
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 MEDIPOST Co., Ltd.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 JCR Pharmaceuticals Co., Ltd.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Astellas Pharma Inc.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Mesoblast Ltd.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Novadip Biosciences S.A.
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Nuvasive Inc
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Molecular Devices Corporation
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Amgen Inc
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 GENEA BIOCELLS
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 WAISMAN BIOMANUFACTURING
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 TIGENIX
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
19 Global Stem Cell Therapy Market- Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global stem cell therapy market was valued at USD 246 million in 2023.
The market is expected to grow at a CAGR of 18.5% during the forecast period of 2024-2032 to reach a value of USD 1133.4 million by 2032.
The increasing awareness pertaining to stem cell therapy, growing prevalence of chronic conditions such as cancer, musculoskeletal and cardiovascular diseases, and advancements in stem cell therapy technology are the major drivers of the market.
The key trends in the market include the increasing geriatric population, improvements in healthcare infrastructure, rising funding towards the research and development activities related to stem cells, and advancements in stem cell sourcing.
Allogeneic stem cell therapy, autologous stem cell therapy, and syngeneic stem cell therapy are the different treatment types in the market.
The various product types in the market are adult stem cell, human embryonic cell, and pluripotent stem cell, among others.
Musculoskeletal disorders, neurological disorders, oncology disorders, cardiovascular disorders, cancer, and wounds and injuries, among others, are the different applications included in the market report.
Stem cell therapy involves administration of stem cells into a patient that help regenerate and repair damaged tissues or organs.
Thermo Fisher Scientific, Bayer AG, Takeda Pharmaceutical Company Limited, MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Astellas Pharma Inc., Mesoblast Ltd., Novadip Biosciences S.A., Nuvasive Inc, and Amgen Inc, among others, are the key players in the stem cell therapy market, according to the report.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER